See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2023_AILERON_THERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 21,873,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 70,000 |
3 | remainder_Assets | 64,000 |
4 | LiabilitiesCurrent | 3,384,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 9,680,000 |
9 | ResearchAndDevelopmentExpense | 17,967,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 318,000 |
13 | remainder_ComprehensiveNetIncome | -35,000 |
yvar | yval | |
---|---|---|
0 | Assets | 22,007,000 |
1 | Liabilities | 3,384,000 |
2 | Expenses | 27,647,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 18,623,000 |
5 | NetIncome | -27,329,000 |
6 | ComprehensiveNetIncome | -27,346,500 |
7 | BaseVar | 26,695,500 |
8 | EconomicCapitalRatio | 0.369 |